Koji Kawakami, a holder of M.D. and Ph.D. degrees, is the Deputy Vice President (Research) and Professor and Chairman in the Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University. After the residency training in head and neck surgery and otorhinolaryngology, Kawakami served as Postdoc and later promoted to Clinical Trial (IND) Reviewer at the Center for Biologics Evaluation and Research (CBER) of the US Food and Drug Administration (FDA) from 1999–2004. Since 2006, Kawakami moved to the Kyoto University Graduate School of Medicine as a Professor of Pharmacoepidemiology, where he is conducting various research programs focusing on the development, evaluation, and cost effectiveness of drugs, biologics, medical devices, and medical care. He has published 90 original articles and 16 review articles in peer-reviewed global scientific journals as of September 2012.
Biography Updated on 4 December 2012